Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$1.88−0.08 (-4.08%)
Close on Nov 19, 2026Market cap $177.76MP/E 4.9Yield –
Compugen gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was $63.51M, up 218.6% from the year before. Over ten years it grew 50.9% a year on average. The highest annual figure on record is $63.51M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $63.51M | +218.6% |
| FY2024 | Dec 31, 2024 | $19.93M | -36.6% |
| FY2023 | Dec 31, 2023 | $31.46M | +382.1% |
| FY2022 | Dec 31, 2022 | $6.53M | +22.7% |
| FY2021 | Dec 31, 2021 | $5.32M | +174.2% |
| FY2020 | Dec 31, 2020 | $1.94M | -88.4% |
| FY2018 | Dec 31, 2018 | $16.77M | +3328.6% |
| FY2016 | Dec 31, 2016 | $489.00K | -93.6% |
| FY2015 | Dec 31, 2015 | $7.64M | -15.3% |
| FY2014 | Dec 31, 2014 | $9.02M | +767.6% |
| FY2013 | Dec 31, 2013 | $1.04M | +2436.6% |
| FY2012 | Dec 31, 2012 | $41.00K | -95.4% |
| FY2010 | Dec 31, 2010 | $891.00K | +256.4% |
| FY2009 | Dec 31, 2009 | $250.00K | – |
See a number that looks wrong?